Company intelligence / Profile preview

Auspi Medicaments

New Delhi, Delhi, India

Ownership: Private
Development stage: Other

Overview

Auspi Medicaments manufactures and markets a wide range of generic small molecule pharmaceuticals in India, with a product portfolio that covers analgesics, antibiotics, antihypertensives, antipyretics, antispasmodics, vitamins, and various OTC formulations. Its products are marketed primarily in the Indian market under several brand names, addressing common and chronic indications such as pain, infection, allergy, hypertension, diabetes, and GI disorders.[2]

Therapeutic areas: ImmunologyCardiovascularEndocrinologyRheumatologyGastroenterologyInfectious DiseasesNeurologyPulmonologyMetabolic Disorders
Modalities: Small moleculeAntibioticVitaminEnzyme replacement therapyPeptidesProteolytic enzymeHormone
Industry: Biotech

Beyond the preview

Go deeper on Auspi Medicaments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Auspi Medicaments.

Explore the full profile